Balmer Lawrie InvestmentsのEV/EBIT
Balmer Lawrie InvestmentsのEV/EBITは何ですか。
Balmer Lawrie Investments LimitedのEV/EBITは1.12です。
EV/EBITの定義は何ですか。
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
BSEのセクタFinanceにおけるEV/EBITの企業と比べるBalmer Lawrie Investments
Balmer Lawrie Investmentsは何をしますか。
Balmer Lawrie Investments Limited, together with its subsidiaries, engages in industrial packaging, greases and lubricants, leather chemicals, logistic services and infrastructure, refinery and oil field, and travel and vacation services businesses in India. The company was incorporated in 2001 and is based in Kolkata, India.
Balmer Lawrie Investmentsと類似のev/ebit
- Pharos plcのEV/EBITは1.09です。
- Jindal Poly Investment and FinanceのEV/EBITは1.10です。
- Olema PharmaceuticalsのEV/EBITは1.10です。
- Kronos BioのEV/EBITは1.11です。
- Harpoon TherapeuticsのEV/EBITは1.12です。
- Public Joint Stock Mining and Metallurgical Norilsk NickelのEV/EBITは1.12です。
- Balmer Lawrie InvestmentsのEV/EBITは1.12です。
- Abraxas PetroleumのEV/EBITは1.13です。
- Antibe TherapeuticsのEV/EBITは1.14です。
- Artelo BiosciencesのEV/EBITは1.15です。
- Artelo BiosciencesのEV/EBITは1.15です。
- Artelo BiosciencesのEV/EBITは1.15です。
- Artelo BiosciencesのEV/EBITは1.15です。